Business Context and Reporting Period
This Form 8-K was filed by PerkinElmer, Inc. (now known as REVVITY, INC.) on December 21, 2016. The report details the entry into a Material Definitive Agreement regarding the divestiture of a specific business segment.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of equity interests in PerkinElmer Medical Holdings, Inc. and Dexela Limited, along with related assets.
- Business Scope: Design, manufacture, and marketing of flat panel x-ray detectors and related software/accessories.
- Purchaser: Varian Medical Systems, Inc.
- Consideration: Approximately $276,000,000 in cash plus the assumption of specified liabilities by the Purchaser.
- Termination Fee: Up to $22,080,000 payable by the Purchaser under specified circumstances.
Material Changes and Strategic Shifts
The filing represents a significant strategic change involving the exit from the flat panel x-ray detector business. The Company agreed to a three-year non-compete covenant following the closing of the transaction, prohibiting engagement in competitive businesses as conducted between January 1, 2016, and the closing date.
Outlook, Conditions, and Risks
- Closing Timeline: The transaction is expected to close no earlier than April 2017, contingent on customary conditions including antitrust waiting periods.
- Financing: The Purchaser intends to finance the transaction through debt financing, though the closing is not conditioned on the receipt of such financing.
- Risks: The transaction is subject to termination rights for both parties. Investors are cautioned not to rely on representations and warranties in the agreement as factual characterizations of the current state of affairs.
Investor Verification Checklist
- Verify the final closing date and whether the April 2017 target is met.
- Confirm the exact amount of liabilities assumed by Varian Medical Systems, Inc.
- Monitor regulatory approvals, specifically the expiration of antitrust waiting periods.
- Review the full text of the Master Purchase and Sale Agreement (Exhibit 2.1) for detailed termination conditions.